{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:14:47Z","timestamp":1787786087025,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hoc.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T07:22:09Z","timestamp":1735284129000},"page":"257-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond"],"prefix":"10.1016","volume":"39","author":[{"given":"Ayesha","family":"Hashmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilli J.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadel A.","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.hoc.2024.11.002_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm.3519","article-title":"An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage","volume":"20","author":"Newman","year":"2014","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nbt.3520","article-title":"Integrated digital error suppression for improved detection of circulating tumor DNA","volume":"34","author":"Newman","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"7655","key":"10.1016\/j.hoc.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"issue":"7957","key":"10.1016\/j.hoc.2024.11.002_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-023-05776-4","article-title":"Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA","volume":"616","author":"Abbosh","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.21.01929","article-title":"Circulating tumor DNA minimal residual disease detection of non-small-cell lung cancer treated with curative intent","volume":"40","author":"Pellini","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2024.11.002_bib7","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2159-8290.CD-21-1486","article-title":"Longitudinal undetectable molecular residual disease defines potentially cured population in localized non-small cell lung cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hoc.2024.11.002_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.8511","article-title":"Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: an update from the PACIFIC trial","volume":"39","author":"Spigel","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.002_bib9","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.21037\/jtd-20-1792","article-title":"Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer","volume":"12","author":"Hassanzadeh","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.002_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/imr.13248","article-title":"CD4 T\u00a0cells and toxicity from immune checkpoint blockade","volume":"318","author":"Earland","year":"2023","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.002_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s43018-019-0011-0","article-title":"Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small cell lung cancer","volume":"1","author":"Moding","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.hoc.2024.11.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.06.024","article-title":"Analysis of circulating tumor DNA predicts outcomes of short-course consolidation immunotherapy in unresectable stage III NSCLC","author":"Jun","year":"2024","journal-title":"J\u00a0Thorac Oncol"},{"issue":"13","key":"10.1016\/j.hoc.2024.11.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107830","article-title":"Senescence, necrosis, and apoptosis govern circulating cell-free DNA release kinetics","volume":"31","author":"Rostami","year":"2020","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.002_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231884","article-title":"Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations","volume":"15","author":"Nygard","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.002_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13014-020-01583-7","article-title":"Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study","volume":"15","author":"Walls","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.hoc.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.lungcan.2022.01.013","article-title":"Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: a first-in-human pilot study","volume":"165","author":"Breadner","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.hoc.2024.11.002_bib17","article-title":"Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC","author":"MacManus","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.hoc.2024.11.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100160","article-title":"Circulating tumor DNA kinetics: a future tool for radiation therapy personalization in lung cancer?","volume":"6","author":"Walls","year":"2024","journal-title":"Journal of Liquid Biopsy"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.002_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.ccell.2023.09.007","article-title":"Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients","volume":"41","author":"Pan","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.002_bib20","article-title":"Circulating tumor DNA analysis during radiation therapy for localized lung cancer predicts treatment outcome","volume":"99","author":"Chaudhuri","year":"2017","journal-title":"IJROBP"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.002_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.hoc.2024.11.002_bib23","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1001\/jama.2012.5521","article-title":"Benefits and harms of CT screening for lung cancer: a systematic review","volume":"307","author":"Bach","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.002_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25102","article-title":"Patient adherence to screening for lung cancer in the US: a systematic review and meta-analysis","volume":"3","author":"Lopez-Olivo","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hoc.2024.11.002_bib26","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-24-0519","article-title":"Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection","author":"Mazzone","year":"2024","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.002_bib27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMoa1208962","article-title":"Results of the two incidence screenings in the national lung screening trial","volume":"369","author":"Aberle","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.hoc.2024.11.002_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archinternmed.2012.332","article-title":"Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies","volume":"172","author":"Inadomi","year":"2012","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.002_bib29","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41467-021-24994-w","article-title":"Detection and characterization of lung cancer using cell-free DNA fragmentomes","volume":"12","author":"Mathios","year":"2021","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.hoc.2024.11.002_bib30","article-title":"Implementing fragmentomics into real world screening interventions to evaluate clinical utility among individuals with elevated risk for lung cancer (FIRSTLUNG) L301","volume":"43","author":"Cotton","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.002_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PPO.0000000000000437","article-title":"Circulating tumor DNA biomarkers for early detection of oligometastasis","volume":"26","author":"Routman","year":"2020","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.002_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41698-023-00440-6","article-title":"Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer","volume":"7","author":"Semenkovich","year":"2023","journal-title":"npj Precis Oncol"},{"issue":"16","key":"10.1016\/j.hoc.2024.11.002_bib33","article-title":"NRG-LU002: randomized phase II\/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC)","volume":"42","author":"Iyengar","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.11.002_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz257.012","article-title":"Analysis of circulating tumour DNA in paired plasma and sputum samples of EGFR-mutated NSCLC patients","volume":"30","author":"Grech","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.11.002_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-020-01408-x","article-title":"Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer","author":"Lee","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.hoc.2024.11.002_bib36","article-title":"Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients","volume":"29","author":"de Kock","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"16","key":"10.1016\/j.hoc.2024.11.002_bib37","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/0008-5472.CAN-22-0554","article-title":"Genomic profiling of bronchoalveolar lavage fluid in lung cancer","volume":"82","author":"Nair","year":"2022","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.002_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.semradonc.2023.03.004","article-title":"Emerging roles of circulating tumor DNA for increased precision and personalization in radiation oncology","volume":"33","author":"Earland","year":"2023","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2024.11.002_bib39","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/1078-0432.CCR-23-1789","article-title":"Sensitive MRD detection from lymphatic fluid after surgery in HPV-associated oropharyngeal cancer","volume":"30","author":"Earland","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.002_bib40","article-title":"Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA","volume":"11","author":"Semenkovich","year":"2023","journal-title":"J\u00a0Immunother Cancer"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T10:42:08Z","timestamp":1750848128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858824001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0889858824001473"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2024.11.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}